Co-diagnostics, inc. ceo delivers manufacturing and commercialization update in conference keynote address

Presentation included announcement of the opening of the new manufacturing facility in salt lake city, ut salt lake city, march 21, 2024 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that in his keynote address at the 5th annual marketsandmarkets conference in london, company ceo dwight egan shared an update on the new manufacturing facilities in salt lake city, utah and in ranoli, india, including announcing the grand opening of the new utah facility next month. both co-dx and cosara diagnostics, the company's joint venture for manufacturing in india, will be manufacturing the co-dx™ pcr pro™ instrument and co-dx pcr test cups that run on the company's new pcr platform*.
CODX Ratings Summary
CODX Quant Ranking